Metabolic research
GLP-3 (RT) Pen – 40 mg
40 mg triple-agonist research pen
GLP-3 (RT) Pen – 40 mg is researched in research peptide comparison, with literature context focused on mechanism, pathway role, and evidence maturity.
This product has an available COA with reported batch details and test results.
Open available COAConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesSolo per ricerca di laboratorio. Non per uso umano o veterinario. Non destinato a diagnosticare, trattare, curare, mitigare o prevenire malattie.
Conservare sigillato, freddo, asciutto e protetto dagli sbalzi di calore. Conferma lo stoccaggio specifico del prodotto all'arrivo.
Imballato per garantire la stabilità del transito con supporto per gli ordini disponibile per le rotte con clima caldo.
Batch-linked certificate support is available through the documentation desk.
Contesto di ricerca
Profilo di ricerca GLP-3 (RT) Pen – 40 mg
GLP-3 (RT) Pen – 40 mg is supplied for controlled laboratory research. Material-specific context and available support are presented separately from external literature. External publications describe their own study materials and methods and do not independently establish the identity, performance, safety, or suitability of this catalog item.
Molecular class
39-residue acylated multi-receptor agonist
Sequence / composition
A 39-amino-acid engineered backbone with non-native substitutions and a C20 fatty-diacid side chain.
Research design note
The lipid side chain is used in pharmacology research to prolong exposure; receptor activity is studied across GIPR, GLP-1R, and GCGR.
Meccanismo proposto
A compound-specific proposed mechanism has not yet been added for GLP-3 (RT) Pen – 40 mg. Confirm molecular identity before assigning a receptor or pathway.
Effetti riportati negli studi
- No compound-specific experimental effects are listed until the molecular identity and literature record are confirmed.
Endpoint di ricerca comuni
Identity, purity, amount, stability, pathway activity, model-specific endpoints, and appropriate controls.
Evidenze e limiti
External literature must be matched to the exact material and study model before conclusions are drawn.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.